38.70 1.10 (2.93%)

31.95% Fall from 52W High

351.6K XNAS Volume

XNAS 08 May, 2025 3:04 PM (EDT)

MoonLake Immunotherapeutics - Ordinary Shares - Class A quarterly, annual results, revenue, profit, P&L, Balance Sheet, Cash Flow, Annual Reports, Margins - 15 Years history